{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:25:14Z","timestamp":1787682314705,"version":"build-2784847793"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-63421-2","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:45:31Z","timestamp":1787679931000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuroprotective potential of synthesized coumarin-based glycinate and heterocyclic amide derivatives: an acetylcholinesterase inhibition study"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5513-9945","authenticated-orcid":false,"given":"Basant","family":"Farag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5246-3491","authenticated-orcid":false,"given":"Wesam S.","family":"Shehab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan F.","family":"Aly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan S.","family":"Kiwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar M.","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gehan T.","family":"El-Bassyouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8139-8548","authenticated-orcid":false,"given":"Doaa A.","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"63421_CR1","doi-asserted-by":"publisher","first-page":"4972","DOI":"10.1021\/acs.jmedchem.1c00048","volume":"64","author":"M Rossi","year":"2021","unstructured":"Rossi, M. et al. Sustainable drug discovery of multi-target-directed ligands for Alzheimer\u2019s disease. Eur. J. Med. Chem. 64, 4972\u20134990 (2021).","journal-title":"Eur. J. Med. Chem."},{"key":"63421_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth, H. W. & LaFerla, F. M. Mechanisms of disease. N Engl. J. Med. 362, 329\u2013344 (2010).","journal-title":"N Engl. J. Med."},{"key":"63421_CR3","doi-asserted-by":"publisher","unstructured":"Elsayed, D.A., Shehab, W.S., Mohammed, J.H. &  Abdu, M.E. A review on advances in multi-target-directed ligands for Alzheimer\u2019s disease. Proc. Int. Exch. Innov. Conf. Eng. Sci. (IEICES) 11, 1756\u20131762. https:\/\/doi.org\/10.5109\/7395742 (2025).","DOI":"10.5109\/7395742"},{"key":"63421_CR4","doi-asserted-by":"publisher","first-page":"15436","DOI":"10.1038\/s41598-024-65166-2","volume":"14","author":"WS Shehab","year":"2024","unstructured":"Shehab, W. S. et al. Pharmacokinetic and molecular docking studies to pyrimidine drug using Mn3O4 nanoparticles to explore potential anti-Alzheimer activity. Sci. Rep. 14, 15436 (2024).","journal-title":"Sci. Rep."},{"key":"63421_CR5","first-page":"407","volume":"65","author":"M Bartolini","year":"2003","unstructured":"Bartolini, M., Bertucci, C., Cavrini, V. & Andrisano, V. \u03b2-Amyloid aggregation induced by human acetylcholinesterase: Inhibition studies. Biochemistry 65, 407\u2013416 (2003).","journal-title":"Biochemistry"},{"key":"63421_CR6","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0197-4580(02)00230-0","volume":"24","author":"T Rees","year":"2003","unstructured":"Rees, T., Hammond, P., Soreq, H., Younkin, S. & Brimijoin, S. Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex. Neurobiol. Aging. 24, 777\u2013787 (2003).","journal-title":"Neurobiol. Aging"},{"key":"63421_CR7","first-page":"165","volume":"70","author":"M Singh","year":"2013","unstructured":"Singh, M. et al. Acetylcholinesterase inhibitors as Alzheimer therapy: From nerve toxins to neuroprotection. Neurosci. Biobehav Rev. 70, 165\u2013188 (2013).","journal-title":"Neurosci. Biobehav Rev."},{"key":"63421_CR8","first-page":"33944","volume":"7","author":"DCF Neto","year":"2017","unstructured":"Neto, D. C. F. et al. A new guanylhydrazone derivative as a potential acetylcholinesterase inhibitor for Alzheimer\u2019s disease: Synthesis, molecular docking, biological evaluation and kinetic studies by nuclear magnetic resonance. Sci. Rep. 7, 33944 (2017).","journal-title":"Sci. Rep."},{"key":"63421_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1749-6632.2000.tb06942.x","volume":"920","author":"E Giacobini","year":"2000","unstructured":"Giacobini, E. Cholinesterase inhibitors stabilize Alzheimer\u2019s disease. Ann. N Y Acad. Sci. 920, 321\u2013327 (2000).","journal-title":"Ann. N Y Acad. Sci."},{"key":"63421_CR10","first-page":"155","volume":"2","author":"SA Lipton","year":"2005","unstructured":"Lipton, S. A. The molecular basis of memantine action in Alzheimer\u2019s disease and other neurologic disorders: Low-affinity, uncompetitive antagonism. CNS Drug Rev. 2, 155\u2013165 (2005).","journal-title":"CNS Drug Rev."},{"key":"63421_CR11","first-page":"362","volume":"21","author":"L Pisani","year":"2016","unstructured":"Pisani, L. et al. Searching for multi-targeting neurotherapeutics against Alzheimer\u2019s: Discovery of potent AChE-MAO B inhibitors through the decoration of the 2H-chromen-2-one structural motif. Eur. J. Med. Chem. 21, 362 (2016).","journal-title":"Eur. J. Med. Chem."},{"key":"63421_CR12","first-page":"1","volume":"31","author":"GP Ellis","year":"1977","unstructured":"Ellis, G. P. Chromenes, chromanones, and chromones\u2014Introduction. Chem. Heterocycl. Compd. 31, 1\u201310 (1977).","journal-title":"Chem. Heterocycl. Compd."},{"key":"63421_CR13","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ejmech.2013.09.034","volume":"70","author":"L Pisani","year":"2013","unstructured":"Pisani, L. et al. Fine molecular tuning at position 4 of 2H-chromen-2-one derivatives in the search of potent and selective monoamine oxidase B inhibitors. Eur. J. Med. Chem. 70, 723\u2013739 (2013).","journal-title":"Eur. J. Med. Chem."},{"key":"63421_CR14","doi-asserted-by":"publisher","first-page":"4960","DOI":"10.1021\/cr400265z","volume":"114","author":"A Gaspar","year":"2014","unstructured":"Gaspar, A., Matos, M. J., Garrido, J., Uriarte, E. & Borges, F. Chromone: A valid scaffold in medicinal chemistry. Chem. Rev. 114, 4960\u20134992 (2014).","journal-title":"Chem. Rev."},{"key":"63421_CR15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ejmech.2014.03.047","volume":"78","author":"RS Keri","year":"2014","unstructured":"Keri, R. S., Budagumpi, S., Pai, R. K. & Balakrishna, R. G. Chromones as a privileged scaffold in drug discovery: A review. Eur. J. Med. Chem. 78, 340\u2013374 (2014).","journal-title":"Eur. J. Med. Chem."},{"key":"63421_CR16","doi-asserted-by":"publisher","first-page":"7941","DOI":"10.1021\/acs.jmedchem.6b01720","volume":"60","author":"J Reis","year":"2017","unstructured":"Reis, J., Gaspar, A., Milhazes, N. & Borges, F. Chromone as a privileged scaffold in drug discovery: Recent advances: Miniperspective. J. Med. Chem. 60, 7941\u20137957 (2017).","journal-title":"J. Med. Chem."},{"key":"63421_CR17","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1021\/np0503808","volume":"69","author":"JS Yoon","year":"2006","unstructured":"Yoon, J. S., Lee, M. K., Sung, S. H. & Kim, Y. C. Neuroprotective 2-(2-phenylethyl) chromones of Imperata cylindrica. J. Nat. Prod. 69, 290\u2013291 (2006).","journal-title":"J. Nat. Prod."},{"key":"63421_CR18","first-page":"83","volume":"5","author":"FI Baptista","year":"2014","unstructured":"Baptista, F. I., Henriques, A. G., Silva, A. M. & Wiltfang, J. da Cruz e Silva OA. Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer\u2019s disease. Aging Cell. 5, 83\u201392 (2014).","journal-title":"Aging Cell."},{"key":"63421_CR19","doi-asserted-by":"publisher","first-page":"7253","DOI":"10.1021\/jm050635e","volume":"48","author":"M Ono","year":"2005","unstructured":"Ono, M. et al. Radioiodinated flavones for in vivo imaging of \u03b2-amyloid plaques in the brain. J. Med. Chem. 48, 7253\u20137260 (2005).","journal-title":"J. Med. Chem."},{"key":"63421_CR20","doi-asserted-by":"publisher","first-page":"18440","DOI":"10.1038\/srep18440","volume":"5","author":"T Fuchigami","year":"2015","unstructured":"Fuchigami, T. et al. Characterisation of radioiodinated flavonoid derivatives for SPECT imaging of cerebral prion deposits. Sci. Rep. 5, 18440 (2015).","journal-title":"Sci. Rep."},{"key":"63421_CR21","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1039\/c1fo10098j","volume":"2","author":"M Dias","year":"2011","unstructured":"Dias, M., Machado, N. & Marques, M. Dietary chromones as antioxidant agents\u2014The structural variable. Food Funct. 2, 595\u2013602 (2011).","journal-title":"Food Funct."},{"key":"63421_CR22","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1002\/cmdc.201600359","volume":"11","author":"CF Silva","year":"2016","unstructured":"Silva, C. F., Pinto, D. C. & Silva, A. M. Chromones: A promising ring system for new anti-inflammatory drugs. ChemMedChem 11, 2252\u20132260 (2016).","journal-title":"ChemMedChem"},{"key":"63421_CR23","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.bmc.2012.10.045","volume":"21","author":"M Catto","year":"2013","unstructured":"Catto, M. et al. Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase. Bioorg. Med. Chem. 21, 146\u2013152 (2013).","journal-title":"Bioorg. Med. Chem."},{"key":"63421_CR24","doi-asserted-by":"publisher","first-page":"5561","DOI":"10.1021\/acs.jmedchem.5b00599","volume":"58","author":"R Farina","year":"2015","unstructured":"Farina, R. et al. Structure-based design and optimization of multitarget-directed 2H-chromen-2-one derivatives as potent inhibitors of monoamine oxidase B and cholinesterases. J. Med. Chem. 58, 5561\u20135578 (2015).","journal-title":"J. Med. Chem."},{"key":"63421_CR25","first-page":"1616","volume":"18","author":"L Pisani","year":"2010","unstructured":"Pisani, L. et al. Design, synthesis, and biological evaluation of coumarin derivatives tethered to an edrophonium-like fragment as highly potent and selective dual binding site acetylcholinesterase inhibitors. Bioorg. Med. Chem. 18, 1616\u20131630 (2010).","journal-title":"Bioorg. Med. Chem."},{"key":"63421_CR26","unstructured":"Adawy, A., Elbassyouni, G. T., Ibrahim, M. & Abd El-Fattah, W. I. Bio Nano Material: The Third Alternative. (Studium Press LLC, 2013)."},{"key":"63421_CR27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s40097-018-0267-4","volume":"8","author":"P Khandel","year":"2018","unstructured":"Khandel, P., Yadaw, R. K., Soni, D. K., Kanwar, L. & Shahi, S. K. Biogenesis of metal nanoparticles and their pharmacological applications: Present status and application prospects. J. Nanostruct. Chem. 8, 217\u2013254 (2018).","journal-title":"J. Nanostruct. Chem."},{"key":"63421_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.21608\/bfszu.2024.299799.1403","volume":"2025","author":"DA Elsayed","year":"2025","unstructured":"Elsayed, D. A., Shehab, W. & Haikal, H. Design, synthesis, and computational studies as cytotoxicity of novel pyrimidine carbonitrile derivatives as dual-target inhibitors of BRD4. Bull. Fac. Sci. Zagazig Univ. 2025, 141\u2013152 (2025).","journal-title":"Bull. Fac. Sci. Zagazig Univ."},{"key":"63421_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.21608\/bfszu.2024.300651.1407","volume":"2025","author":"W Shehab","year":"2025","unstructured":"Shehab, W. Computational chemistry for some novel pyrimidine derivatives as significant antioxidants using cytochrome c peroxidase enzyme. Bull. Fac. Sci. Zagazig Univ. 2025, 171\u2013177 (2025).","journal-title":"Bull. Fac. Sci. Zagazig Univ."},{"key":"63421_CR30","first-page":"1","volume":"179","author":"S Menon","year":"2019","unstructured":"Menon, S., KS, S. D., Agarwal, H. & Shanmugam, V. K. Efficacy of biogenic selenium nanoparticles from an extract of ginger towards evaluation on antimicrobial and antioxidant activities. Colloids Surf. B Biointerfaces. 179, 1\u20138 (2019).","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"63421_CR31","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3390\/molecules29040801","volume":"29","author":"S Sampath","year":"2024","unstructured":"Sampath, S., Sunderam, V., Manjusha, M., Dlamini, Z. & Lawrance, A. V. Selenium nanoparticles: A comprehensive examination of synthesis techniques and their diverse applications in medical research and toxicology studies. Molecules 29, 801 (2024).","journal-title":"Molecules"},{"key":"63421_CR32","first-page":"2300098","volume":"40","author":"Y Huang","year":"2023","unstructured":"Huang, Y. et al. A review of selenium (Se) nanoparticles: From synthesis to applications. Adv. Mater. 40, 2300098 (2023).","journal-title":"Adv. Mater."},{"key":"63421_CR33","doi-asserted-by":"publisher","first-page":"26775","DOI":"10.1038\/s41598-024-77353-2","volume":"14","author":"MK Soliman","year":"2024","unstructured":"Soliman, M. K., Amin, M. A. A., Nowwar, A. I., Hendy, M. H. & Salem, S. S. Green synthesis of selenium nanoparticles from Cassia javanica flowers extract and their medical and agricultural applications. Sci. Rep. 14, 26775 (2024).","journal-title":"Sci. Rep."},{"key":"63421_CR34","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1007\/s00339-021-05051-1","volume":"127","author":"M Mabrouk","year":"2021","unstructured":"Mabrouk, M., Mousa, S. M., ElGhany, W. A., Abo-elfadl, M. T. & El-Bassyouni, G. T. Bioactivity and cell viability of Ag+- and Zr4+-co-doped biphasic calcium phosphate. Appl. Phys. A. 127, 948 (2021).","journal-title":"Appl. Phys. A"},{"key":"63421_CR35","doi-asserted-by":"publisher","first-page":"e00787","DOI":"10.1016\/j.btre.2023.e00787","volume":"37","author":"M Pescuma","year":"2023","unstructured":"Pescuma, M. et al. Biogenic selenium nanoparticles with antifungal activity against the wood-rotting fungus Oligoporus pelliculosus. Biotechnol. Rep. 37, e00787 (2023).","journal-title":"Biotechnol. Rep."},{"key":"63421_CR36","doi-asserted-by":"publisher","first-page":"123969","DOI":"10.1016\/j.ijpharm.2024.123969","volume":"654","author":"M Moaness","year":"2024","unstructured":"Moaness, M., Mousa, S. M., Abo-Elfadl, M. T. & El-Bassyouni, G. T. Doxorubicin loaded cerium substituted hydroxyapatite nanoparticles: A promising new therapeutic approach for bone regeneration, doxorubicin delivery, and cancer treatment. Int. J. Pharm. 654, 123969 (2024).","journal-title":"Int. J. Pharm."},{"key":"63421_CR37","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41598-019-57333-7","volume":"10","author":"M Vahdati","year":"2020","unstructured":"Vahdati, M. & Tohidi Moghadam, T. Synthesis and characterization of selenium nanoparticles-lysozyme nanohybrid system with synergistic antibacterial properties. Sci. Rep. 10, 510 (2020).","journal-title":"Sci. Rep."},{"key":"63421_CR38","first-page":"867","volume":"14","author":"A Shar","year":"2019","unstructured":"Shar, A. et al. Facile synthesis and characterization of selenium nanoparticles by the hydrothermal approach. Dig. J. Nanomater Biostruct. 14, 867\u2013872 (2019).","journal-title":"Dig. J. Nanomater Biostruct"},{"key":"63421_CR39","doi-asserted-by":"publisher","first-page":"241","DOI":"10.36468\/pharmaceutical-sciences.504","volume":"81","author":"A Gawai","year":"2019","unstructured":"Gawai, A., Das, S. & Nemade, M. Synthesis, preliminary pharmacological and acute toxicity studies of a new series of 7-(2-(benzo[d]thiazol-2-ylamino)ethoxy)-4-methyl-2H-chromen-2-one derivatives with atypical antipsychotic activity. Indian J. Pharm. Sci. 81, 241\u2013248 (2019).","journal-title":"Indian J. Pharm. Sci."},{"key":"63421_CR40","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1002\/cber.188301602117","volume":"16","author":"H Von Pechmann","year":"1883","unstructured":"Von Pechmann, H. & Duisberg, C. Ueber die verbindungen der phenole mit acetessig\u00e4ther. Ber Dtsch. Chem. Ges. 16, 2119\u20132128 (1883).","journal-title":"Ber Dtsch. Chem. Ges"},{"key":"63421_CR41","first-page":"8170","volume":"17","author":"A Bu\u017ekov\u00e1","year":"2025","unstructured":"Bu\u017ekov\u00e1, A. et al. Selenium nanoparticles: Influence of reducing agents on particle stability and antibacterial activity at biogenic concentrations. Sci. Rep. 17, 8170\u20138182 (2025).","journal-title":"Sci. Rep."},{"key":"63421_CR42","doi-asserted-by":"crossref","unstructured":"El-Saadony, M. T. et al. Selenium nanoparticles: Eco-friendly synthesis, biological activities and biomedical applications a comprehensive review. Biomed. Pharmacother. 2026, 102946 (2026).","DOI":"10.1016\/j.mtbio.2026.102946"},{"key":"63421_CR43","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3109\/17435390.2011.587904","volume":"6","author":"TJ MacCormack","year":"2012","unstructured":"MacCormack, T. J. et al. Inhibition of enzyme activity by nanomaterials: Potential mechanisms and implications for nanotoxicity testing. Nanotoxicology 6, 514\u2013525 (2012).","journal-title":"Nanotoxicology"},{"key":"63421_CR44","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1477-3155-11-26","volume":"11","author":"SR Saptarshi","year":"2013","unstructured":"Saptarshi, S. R., Duschl, A. & Lopata, A. L. Interaction of nanoparticles with proteins: Relation to bio-reactivity of the nanoparticle. J. Nanobiotechnol. 11, 26 (2013).","journal-title":"J. Nanobiotechnol."},{"key":"63421_CR45","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1039\/C4AN01639D","volume":"140","author":"B Saha","year":"2015","unstructured":"Saha, B., Saikia, J. & Das, G. Correlating enzyme density, conformation and activity on nanoparticle surfaces in highly functional bio-nanocomposites. Analyst 140, 532\u2013542 (2015).","journal-title":"Analyst"},{"key":"63421_CR46","doi-asserted-by":"publisher","first-page":"2232125","DOI":"10.1080\/14756366.2023.2232125","volume":"38","author":"S El-Kalyoubi","year":"2023","unstructured":"El-Kalyoubi, S. et al. Novel pyrimidine Schiff bases and their selenium-containing nanoparticles as dual inhibitors of CDK1 and tubulin polymerase: Design, synthesis, anti-proliferative evaluation, and molecular modelling. J. Enzyme Inhib. Med. Chem. 38, 2232125 (2023).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"63421_CR47","doi-asserted-by":"crossref","first-page":"18496","DOI":"10.1038\/s41598-023-37353-0","volume":"13","author":"NN Kamel","year":"2023","unstructured":"Kamel, N. N. et al. Anti-Alzheimer activity of new coumarin-based derivatives targeting acetylcholinesterase inhibition. Sci. Rep. 13, 18496\u201318510 (2023).","journal-title":"Sci. Rep."},{"key":"63421_CR48","doi-asserted-by":"crossref","unstructured":"Rizk, M. Z. et al. Modulatory potential of a novel benzofuran-derived compound against aluminium chloride-induced neurotoxicity and miRNA dysregulation: Biochemical and bio-analytical study. Neurochem. Int.  2025, 102148 (2025).","DOI":"10.1016\/j.toxrep.2025.102148"},{"key":"63421_CR49","first-page":"38","volume":"48","author":"HF Aly","year":"2026","unstructured":"Aly, H. F. et al. Evaluating the therapeutic efficacy of a benzofuran-enaminone derivative for the management of Alzheimer\u2019s disease (AD)-like pathology in rats through regulating the expression of apoptosis and AD-related genes. Biomed. Pharmacother. 48, 38\u201352 (2026).","journal-title":"Biomed. Pharmacother"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63421-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63421-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63421-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:02:45Z","timestamp":1787680965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63421-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["63421"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-63421-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26684"}}